These results, together with a prior report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 help the strategy of targeting ACKR3 as a singular approach to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-related Diseases. As well as the described https://battistaq936png6.blogdeazar.com/profile